Results 211 to 220 of about 53,199 (230)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy

Kidney International Reports, 2018
Thangamani Muthukumar, Surya V Seshan, David Serur   +2 more
exaly  

Bortezomib

Reactions Weekly, 2021
openaire   +1 more source

Gene expression analysis of B‐lymphoma cells resistant and sensitive to bortezomib*

British Journal of Haematology, 2006
Hidde Ploegh, Klaus Podar, Kessler Benedikt M   +2 more
exaly  

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150

Annals of Oncology, 2007
Randy Gascoyne, M Crump, A Belch
exaly  

Bortezomib

Reactions Weekly, 2013
openaire   +1 more source

Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1

Blood, 2008
Yang-Sook Chun, Eric Huang, Jong-Wan Park   +2 more
exaly  

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Lancet, The, 2020
Roman Hajek, Thierry Facon, Meletios Dimopoulos   +2 more
exaly  

Bortezomib

Reactions Weekly, 2014
openaire   +1 more source

A Targeted and pH-Responsive Bortezomib Nanomedicine in the Treatment of Metastatic Bone Tumors

ACS Applied Materials & Interfaces, 2018
Lei Li, Changping Wang, Xiaopan Cai
exaly  

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

Blood, 2011
Louis Staudt, Patricia Perez-Galan
exaly